IRCON Q2 FY27: consolidated PAT falls 26% YoY to ₹100 Cr as margins compress
PAT -26.5% YoY · revenue +14.92% · margins compressing
₹2,271.66 Cr
+14.92% YoY
₹100.34 Cr
-26.5% YoY
4.24%
-2.2pp YoY
₹1.09
IRCON's consolidated PAT fell 26.5% YoY to ₹100.34 Cr (from ₹136.51 Cr in Q2 FY26) even as revenue grew 14.9% YoY to ₹2,271.66 Cr — a classic growth-without-profit print. Net profit margin compressed to 4.24% from 6.46% a year ago, running well below management's own 6-7% PAT-margin guidance given on the last concall; H1 FY27 consolidated revenue of ₹4,406.47 Cr also annualises to roughly ₹8,800 Cr, trailing the ₹10,000-11,000 Cr FY27 revenue band management had guided. We found no published Street consensus estimate specifically for this quarter, so vsStreet is unknown rather than inferred — brokerage commentary earlier in the year had already flagged a subdued FY27 outlook on margin pressure.
Q2 FY-2027 vs prior quarters
Two items explain most of the margin bridge. First, the equity-method share of joint-venture results swung to a ₹11.20 Cr loss this quarter from a ₹20.39 Cr profit a year ago — a roughly ₹31.6 Cr negative swing tied to the ongoing wind-down of JVs flagged in the filing notes (IRSDC's voluntary liquidation and ISTPL's toll-concession expiry in May 2026). Second, the effective tax rate jumped to 37.1% (₹59.25 Cr tax on ₹159.59 Cr PBT) from 20.8% a year ago, driven by a ₹12.74 Cr prior-year tax true-up that barely featured last quarter (₹0.01 Cr). Standalone (parent-only, no JV pickup) tells a sharper version of the same story: PAT fell 34.0% YoY to ₹121.92 Cr and 25.4% QoQ — a steeper decline than consolidated's, so readers comparing the two numbers should note the divergence is real, not a reporting error.
The stock went into the print at ₹103.5, down 3.2% over the past month of trading.
Management guides for FY26 operating revenue of Rs. 10,000-11,000 crore, with similar levels expected in FY27, and targets H2 order inflows comparable to H1's Rs. 4,000+ crore. Future PAT margins are expected in the 6-7% range, reflecting significant pressure from intense competition which has necessitated a strategic
— This quarter: missed
On corporate developments, the quarter closed against a backdrop of a ₹72.41 Cr GST notice (court hearing held October 26) and a September 23 arbitration award of ₹147 Cr against an IRCON claim — both disclosed as regulatory/legal matters rather than booked exceptional items in this result (the exceptional-items line is nil throughout). Early Q3 order wins — a ₹862.46 Cr EPC contract from East Central Railway (October 12) and a ₹96.25 Cr maintenance contract from Konkan Railway (October 9) — give some read-through on management's stated goal of matching H1's 4,000+ Cr order inflow in H2, though neither falls inside this reporting quarter. No management press release accompanied this filing beyond the board-meeting intimation, so there is no fresh management commentary to reconcile against the numbers this time.
W1
PAT margin trajectory toward management's guided 6-7% band — currently running at ~4.2-4.5% over H1 FY27
W2
H2 order inflows vs management's own benchmark of matching H1's ₹4,000+ Cr — October alone added ~₹958.71 Cr (₹862.46 Cr East Central Railway + ₹96.25 Cr Konkan Railway)
W3
Resolution of the ₹72.41 Cr GST notice (hearing held Oct 26) and the ₹147 Cr arbitration award against IRCON's claim (Sept 23) — both currently outside the exceptional-items line
No exceptional items in any period shown; consolidated PBT includes a swing in JV equity income to -11.20 Cr (from +20.39 Cr YoY) and both statements carry a ~12.7 Cr prior-year tax true-up; standalone PAT is fully owner-attributable, consolidated PAT of 100.34 Cr is total-for-period (owners' share 102.87 Cr, NCI -2.53 Cr) — used for YoY/QoQ comparability with prior DB figures.
Execution quickens amid margin pressure; FY27 revenue guidance cut
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
FY27 revenue guidance cut from 10,000–11,000 to 9,000–9,500 Cr; Q2 PAT margin missed (4.2% vs 6–7% guided).
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
IRCON is executing faster (QoQ +16.1% revenue) with a solid order book (21,296 Cr = 2.2x revenue), but profit margins have collapsed (PAT −26.5% YoY, NPM 4.2% vs guided 6–7%), and order intake is falling short (₹1,000 Cr won vs ₹9,000–10,000 Cr target). The company cut FY27 revenue guidance from prior 10,000–11,000 Cr to 9,000–9,500 Cr. Without evidence of margin recovery or order book replenishment, near-term momentum is uncertain.
₹2271.7 Cr
Revenue · +14.9% YoY₹100.3 Cr
Reported PAT · −26.5% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Order book 2x annual revenue; competitive positioning intact
METOrder book 21,296 Cr ÷ ~9,500 Cr expected FY27 = 2.24x; 55% competitive, 45% nomination
PAT margins will be 6–7% for full year
MISSQ2 delivered NPM 4.2% (PAT 100.3 ÷ revenue 2271.7); YoY PAT -26.5 despite revenue +14.9%
EBITDA margins 8–9% consol basis
METQ2 EBITDA 227 Cr ÷ 2272 Cr revenue = 10% OPM; beats stated 8–9% range
Targeting INR 9,000–10,000 Cr order inflows FY27
OVERSTATEDOnly INR 1,000 Cr new orders won by end Q2 (50% of year); 10% of annual target achieved
FY27 revenue 9,000–9,500 Cr (5–6% growth)
METQ1+Q2 run-rate suggests ~9,600–9,800 Cr annualized; on track at midpoint but downgraded from prior 10,000–11,000 Cr expectation
Earnings quality
What changed since the last call
FY27 revenue guidance cut
DowngradePrior FY26 call guided ₹10,000–11,000 Cr for FY27; now guiding ₹9,000–9,500 Cr (−5% midpoint)
Order inflow momentum weak
DowngradeTargeting ₹9,000–10,000 Cr FY27 inflows; only ₹1,000 Cr won by end Q2. Management cites 'challenging operational environment' and competitive intensity; previously expected higher intake
Margin guidance reaffirmed despite miss
NeutralQ2 NPM 4.2% vs guided 6–7% PAT; management attributes to one-offs (tax ₹12–13 Cr, other income timing) and maintains full-year 6–7% PAT target
International order target reset
NewAiming to grow international orders from current 9% to 15% of order book (no quantified timeline given; described as ongoing strategy shift)
The Q&A
Analysts pressed hard on margin guidance (management held firm: 6–7% PAT, 8–9% EBITDA), order intake risk (management cited competitive bidding strategy), and FY28 outlook (management demurred, citing market volatility, willing to give color 'few months down the line'). Overall: direct answers on past performance, hedged on forward outlook.
Liquidity / own funds — Gaurav, individual investor
AnsweredINR 800–900 crore on books; using own cash to fund projects, working capital loan (₹100 Cr nominal) being repaid
Order intake strategy — Gaurav, individual investor
PartialTargeting INR 9,000–10,000 Cr orders for year; focusing on larger overseas works (railways, highways, international markets); bidding competitively; hopeful for larger orders as competition eases
International expansion — Gaurav, individual investor
AnsweredCurrently 9% international, aiming for 15%; bidding in Algeria, African nations, Eastern Europe; domestic railways/highways are two focus sectors; no major geopolitical impact yet
Other income volatility — Gaurav, individual investor
AnsweredPPP project dividend (legacy) ended; new HAM projects in construction stage (no revenue yet, expected to complete by year-end); exchange rate lower than prior year; cash/surplus being deployed into equity for PPP projects, reducing interest income
Subsidiary investments — Divesh Deria, individual investor
AnsweredINR 3,100 Cr+ invested across renewable power projects, PPP road assets, coal connectivity JVs; expecting INR 800–900 Cr additional investment in ongoing SPVs/HAM projects under construction
JV profitability — Divesh Deria, individual investor
AnsweredCoal connectivity projects (e.g., CERL) in teething phase; infrastructure ready but coal supply/logistics still developing. Expect breakeven after 2 years; losses reducing. HAM projects ramp over time.
Working capital loan — Divesh Deria, individual investor
AnsweredLast year used nominal ₹100 Cr as contingency for projects with large WC needs; now primarily using own cash and bank balance to fund projects; minimal reliance on WC loan
Order book / execution guidance — Vishal Periwal, PL Capital
Partial5–6% growth expected FY27 (₹9,000–9,500 Cr operating turnover). Key projects: Sivok (₹2,000–2,500 Cr pipeline), T-2 bullet train (₹3,000–3,500 Cr). Execution accelerating (Q2 up 16.1% QoQ).
Tax rate normalization — Vishal Periwal, PL Capital
AnsweredSri Lanka project completion triggered tax liability INR 12–13 Cr one-off. Full-year tax rate should normalize to 23–24% after this one-off; 'without it' implied this quarter alone spiked it
Order inflow details — Vishal Periwal, PL Capital
AnsweredH1 inflow close to INR 1,000 Cr. Sivok ~INR 2,000–2,500 Cr pending. T-2 ~INR 3,000–3,500 Cr pending. Quoted ~INR 25,000 Cr in domestic highways/railways waiting for opening.
Margin guidance sustainability — Dev Ketan Sethia, individual investor
AnsweredMaintaining PAT margin guidance of 6–7% standalone; EBITDA margins 8–9% consol basis. Will maintain, reaffirmed.
Order book decline — Bhavesh Jain, individual investor
AnsweredOrder book declining as projects execute. 2x leverage maintained (21,296 Cr ÷ ~9,500 Cr revenue = 2.2x). Strategy: aggressive bidding on competitive tenders, overseas focus for better margins, domestic railways/highways priority. INR 25,000 Cr quoted, awaiting opens.
Tax rate future — Bhavesh Jain, individual investor
AnsweredOne-off Sri Lanka tax liability INR 12–13 Cr explained; normalized 23–24% going forward; full year ~23–24% expected
Railway sector outlook — Gaurav (follow-up)
AnsweredRailways large-sized market; good opportunity ahead. Budget remains large, tenders coming. Competition is intense in railways (like highways), but focus area. RFQ bids submitted, awaiting awards.
FY27 revenue and FY28 outlook — Manoj Shah, Laxco Investments
PartialOrder book target INR 25,000 Cr by March 2027; revenue INR 9,500–10,000 Cr FY27. FY28 depends on orders secured; conservative approach; will see momentum 'few months down the line'; volatile market, too early to guide
Momentum sustainability FY28 — Manoj Shah, Laxco Investments
PartialHistory shows slowdown FY26–27. Focus on execution, faster execution this year (evidenced by 16.1% QoQ growth). Better position to see momentum direction 'few months down the line'; similar order book levels expected.
RVNL–Ircon merger — Manoj Shah, Laxco Investments
AnsweredNo knowledge whatsoever. Being listed company, governance requires immediate disclosure if such material event known. As of now, no.
Guidance
FY27 operating turnover ₹9,000–9,500 Cr
Medium5–6% YoY growth; implies H2 needs ~₹4,400–4,600 Cr (higher than H1 run-rate). Order book visibility good (21,296 Cr), but order intake slow (₹1,000 Cr H1 vs ₹9,000–10,000 Cr target)
Order inflows target ₹9,000–10,000 Cr FY27
LowOnly ₹1,000 Cr won by Q2 (10% of target); ₹25,000 Cr quoted in domestic market awaiting opens; H2 required to accelerate sharply
PAT margins 6–7% standalone basis
LowQ2 delivered 4.2% NPM; reaffirmed full-year despite Q2 miss; one-offs (tax ₹12–13 Cr, other income timing) blamed; margin pressure from competitive bidding unresolved
EBITDA margins 8–9% consol basis
HighQ2 delivered 10% OPM (exceeds guidance); EBITDA track record strong; reaffirmed
PPP/HAM project investments ₹800–900 Cr additional FY27
MediumOngoing capital deployment into renewables, road assets, coal connectivity SPVs under construction; no formal capex target disclosed
Risks the call surfaced
Margin compression
HighPAT margins guided 6–7% but Q2 delivered 4.2% NPM; YoY PAT down 26.5% despite +14.9% revenue. 55% of orders on competitive bidding; pricing power limited.
Order intake shortfall
HighTargeting ₹9,000–10,000 Cr annual order inflows; only ₹1,000 Cr won by Q2 (10% of target). ₹25,000 Cr quoted awaiting opens; no certainty of conversion.
FY27 revenue miss risk
MediumGuided ₹9,000–9,500 Cr (cut from prior 10,000–11,000 Cr). H1 running ~₹4,400 Cr; H2 needs ~₹4,600–4,900 Cr. Execution acceleration (16.1% QoQ) helps, but slower order intake increases slippage risk.
Subsidiary loss drag
MediumCoal connectivity JVs (CERL, others) in teething phase with ongoing losses; expect 2+ years to breakeven. ₹3,100+ Cr invested; no current profit contribution; cash deployment reducing interest income.
International expansion execution risk
MediumTargeting 15% of order book from international (currently 9%); bidding aggressively in Algeria, African nations, Eastern Europe. No track record of large international contract execution to date.
Management
Score 7/10. Clear on financials and strategy (6–7% PAT, 8–9% EBITDA margins reaffirmed); transparent on order intake challenges and one-off items (Sri Lanka tax, other income timing). Hedged on forward-looking statements ('few months down the line', 'volatile market'), which limits visibility but is honest. Q2 revenue +14.9% YoY, +16.1% QoQ shows execution acceleration; order book at 2.2x revenue provides visibility. But order intake shortfall (₹1,000 Cr of ₹9,000–10,000 Cr target) and margin miss (4.2% NPM vs 6–7% guided) suggest execution gaps vs prior guidance.
1 · H2 FY27
Large order wins (overseas Algeria, Sri Lanka, Eastern Europe) to revive intake
2 · Feb 2027
Management expects market visibility/momentum clarity; potential for guidance uplift
3 · FY28
Coal connectivity projects (CERL, others) expected to breakeven after teething losses
Without evidence of margin recovery or order book replenishment, near-term momentum is uncertain.
Execution Quickens But Profit Slumps 26% — Margin Guidance Looks Untenable
IRCON's Q2 revenue jumped 14.9% YoY and execution accelerated 16.1% QoQ, the operational story looks solid. But PAT plummeted 26.5% YoY to ₹100 Cr (NPM just 4.2%) — contradicting management's 6–7% margin target by 260 basis points. The stock has repriced -69.6% from its ATH, reflecting the market's read: a business grinding through structural margin pressure despite headline growth.
The Quarter in One Tension
IRCON reported Q2 revenue of ₹2,272 Cr (+14.9% YoY, +16.1% QoQ) and operationally the company is moving: execution is accelerating, order book at ₹21,296 Cr (2.2x revenue) provides 9–12 months visibility, and EBITDA margins hit 10% — better than the 8–9% guided. The headline ought to read like a solid operational quarter. Except profit collapsed: PAT fell ₹26.5% YoY to ₹100 Cr, and the net margin compressed to just 4.2% — a full 260 basis points below management's reaffirmed guidance of 6–7%. This is not a timing miss. This is structural margin pressure meeting the tape.
₹100 Cr
NPM 4.2% | YoY −26.5%
6–7%
Full-year reaffirmed
260 bps
Already mid-year, unresolved
Where the Profit Went
Management attributes the Q2 PAT miss to two one-offs: a ₹12–13 Cr tax hit from the Sri Lanka project completion, and a collapse in other income (legacy PPP dividend ended, new HAM projects still in construction, forex headwind on cash holdings). Fair points — these are non-recurring pressures. Adjust for them and underlying PAT might sit ~₹115–120 Cr, or roughly 5.0–5.3% margin. Still 90–140 bps short of the 6–7% target. The deeper issue: EBITDA at 10% is strong, but competitive bidding pressure (55% of the order book is on competitive bids) is compressing the path from EBITDA down to PAT. Other income and tax timing are icing; the cake is margin compression from operational intensity.
The reaffirmed 6–7% PAT margin guidance is now questionable. Even stripping one-offs, the data already contradicts it. Either management sees a sharp margin recovery in H2 (possible if higher-margin international orders are awarded), or the guidance is aspirational rather than grounded.
What Changed on This Call
FY27 revenue guidance cut from ₹10,000–11,000 Cr to ₹9,000–9,500 Cr (−5% midpoint)
Order inflow target introduced at ₹9,000–10,000 Cr FY27; only ₹1,000 Cr won by Q2 (10% of target)
International order ambition raised from current 9% to target 15% of order book (Algeria, Africa, Eastern Europe)
PAT margin guidance reaffirmed at 6–7% despite Q2 delivery of 4.2%
Management's Claims vs. What Holds Up
Order book 2.2x annual revenue; competitive positioning intact
₹21,296 Cr ÷ ~₹9,500 Cr FY27 guidance = 2.24x; 55% competitive, 45% nomination-based
Supported
PAT margins will be 6–7% for full year (reaffirmed Q2 call)
Q2 delivered NPM 4.2% (₹100 Cr ÷ ₹2,272 Cr); YoY PAT −26.5% despite revenue +14.9%
Contradicted
EBITDA margins 8–9% consol basis
Q2 delivered OPM 10% (₹227 Cr EBITDA ÷ ₹2,272 Cr revenue)
Supported, exceeded
Targeting ₹9,000–10,000 Cr order inflows in FY27
Only ₹1,000 Cr new orders won by end Q2; need ₹8,000–9,000 Cr in H2 (high bar)
Overstated (10% of target achieved at midyear)
FY27 revenue ₹9,000–9,500 Cr (5–6% growth, down from prior 10,000–11,000 Cr)
H1 run-rate ~₹4,400 Cr annualizes to ~₹9,600–9,800 Cr; on track at midpoint of guidance
Supported (but downgraded from prior call)
The Bull-Bear Ledger
Execution momentum is real: Q2 QoQ +16.1% revenue growth shows operational delivery
Order book at 2.2x revenue; stable domestic (91%) and growing international (9% → 15% target)
EBITDA margins at 10% exceed guidance; underlying operating leverage intact
Sivok (₹2–2.5k Cr) and T-2 bullet train (₹3–3.5k Cr) execution ramping; large domestic railway/highway market opportunity (₹25k Cr quoted)
PAT -26.5% YoY despite revenue +14.9% — margin compression is structural, not one-time
Q2 NPM 4.2% vs 6–7% guided is a 260 bps miss; even adjusting for Sri Lanka tax and other income, underlying margin is ~5.0–5.3%
Order intake only ₹1,000 Cr of ₹9,000–10,000 Cr target by mid-year; H2 needs extreme acceleration
FY27 revenue guidance cut 5% midpoint from prior call; order inflow target only 10% achieved by Q2
55% of order book on competitive bids; pricing power limited; PAT margin guidance unachievable without margin recovery or order mix shift
Subsidiary losses ongoing (coal connectivity ₹3.1k Cr+ invested, 2+ years to breakeven); capex deployment reducing interest income
Risks, Ranked by How Much They Should Concern a Holder
Margin compression unresolved
HighQ2 NPM 4.2% vs 6–7% guided is 260 bps; 55% of orders on competitive bidding; even adjusted for one-offs, underlying margin ~5.0–5.3%. Reaffirmed guidance looks untenable without order mix shift or dramatic H2 recovery.
Order intake shortfall
High₹1,000 Cr won by Q2 vs ₹9,000–10,000 Cr annual target (10% achievement); need ₹8,000–9,000 Cr in H2 to hit guidance. ₹25k Cr quoted in domestic market awaiting opens, but conversion risk is real in competitive environment.
FY27 revenue miss
MediumDowngraded from prior 10,000–11,000 Cr guidance to 9,000–9,500 Cr. H1 on track, but slow order intake increases H2 execution risk. If H2 orders don't materialize, full-year revenue will slip below ₹9,000 Cr.
Subsidiary losses drag ongoing
Medium₹3,100+ Cr invested in coal connectivity JVs and HAM projects; still 2+ years to breakeven. Capital deployment reducing interest income. No near-term profit contribution; losses expected to reduce only gradually.
International expansion unproven
MediumBidding to shift international orders from 9% to 15% (Algeria, Africa, Eastern Europe). No track record of large-scale international contract execution. Geopolitical and execution risks unquantified; pitch is margin uplift, but delivery uncertain.
FY28 macro visibility absent
MediumManagement deferred FY28 guidance, citing 'volatile and sensitive market'. Without order inflow certainty for H2 FY27, forward visibility is opaque. Risk of further guidance cuts if H2 intake disappoints.
How the Street is Positioned
The market has already voted on this quarter. IRCON trades at ₹106.75, down −69.6% from its all-time high of ₹351.6, and is now trading below its SMA50 (₹108.89) and SMA200 (₹131.79) — a downtrend confirmed. The stock is +11.5% off the 52-week low of ₹95.76 but has ceded massive value. RSI at 54.4 is neutral — no extreme oversold condition, so further downside pressure is possible.
Institutional flows are negative. FII ownership fell from 4.78% (FY26 Q4) to 4.60% (FY27 Q1), a −18 bps pullback in this quarter. DII ownership is static at 1.79%. Promoter holding unchanged at 65.17%. The institutional trimming reflects a repricing: IRCON is being downgraded from a steady execution story to a business grinding through structural margin pressure. The vast drawdown (−69.6% from ATH) is the market's honest read — not a cyclical dip, but a fundamental repricing of earnings quality.
The street's verdict mirrors the fundamentals. Execution is accelerating but profit is decelerating; guidance was cut and is now at risk again; order intake is lagging; and margin recovery is no longer assumed. At a 2.24x order book multiple with deteriorating profitability and competitive intensity unabated, the stock is catching down to a lower earnings quality.
The Debate
What to Watch Next
1 · H2 order inflows: ₹8,000–9,000 Cr required
Did IRCON win large orders in railways, highways, overseas markets? The ₹25k Cr quoted in domestic railways/highways is the opening. Failure to convert even ₹50% of it (₹12.5k Cr quoted, some wins expected) signals order intake is broken, not just slow.
2 · Q3 PAT margin: Will it improve or slip further?
If Q3 NPM stays below 5%, the 6–7% full-year guidance is unrealistic. Any margin recovery would need to show by Q3 to justify a full-year 6–7% claim. Flat or declining margins into Q4 would confirm structural compression.
3 · International order awards and order book mix
Is IRCON shifting from 9% international to 15%? Are the higher-margin international deals winning? This is the bull's last lever — but unproven. Large international contract awards (Algeria, Africa) would validate the strategy; a quiet H2 on this front raises execution risk.
Execution is quickening, but profit is slowing. This is not a cyclical quarter — it's a repricing of the business as margin-constrained and order-intake-lagging. The ₹4.2% PAT margin in Q2 vs the ₹6–7% guided is not noise; it's the new reality. Management is reaffirming guidance that the data has already contradicted. Without demonstrated margin recovery (not just hoped-for international order wins), the balance of risk is downside. The market's −69.6% drawdown from ATH reflects this honestly. The number to track from here is the organic PAT margin — if it stays below 5% into Q3, guidance is finished.